Advancing Parkinson’s Disease Treatments: Disease-Modifying and Non-Motor Symptom Therapies
Reading Time: 4 minutes
Introduction
Parkinson’s disease (PD) is a complex, progressive neurodegenerative disorder marked by both motor and non-motor symptoms. Recent therapeutic advancements are expanding beyond symptomatic management to explore disease-modifying therapies (DMTs) aimed …
Read MoreBarriers in Parkinson’s Disease
Reading Time: 3 minutes
Introduction
Parkinson’s disease (PD) is a neurodegenerative disorder that targets dopamine-producing neurons in the brain’s substantia nigra and basal ganglia, leading to a spectrum of motor and nonmotor symptoms. A growing …
Read MoreNews Takeaway: Semaglutide’s Potential Role in Alzheimer’s Prevention – A Closer Look
Reading Time: 2 minutes
SummarySemaglutide, commonly prescribed for diabetes and obesity, is now showing promise in potentially lowering Alzheimer’s risk. Recent findings, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, suggest …
Targeting Alpha-Synuclein in Parkinson’s
Reading Time: 4 minutes
Introduction
Recent research has unveiled promising strategies to treat Parkinson’s disease (PD), focusing on targeting alpha-synuclein clumping and its transmission between brain cells. Understanding the role of cell surface proteins like …
Read MorePromising GLP-1 Drugs for Parkinson’s and Alzheimer’s
Reading Time: 3 minutes
Introduction
In recent years, a class of diabetes drugs, known as GLP-1 receptor agonists, has shown significant potential in treating not just diabetes but also neurodegenerative conditions like Parkinson’s disease (PD) …
Read More